I agree that this site is using cookies. You can find further informations here.
X
Ropert, Stanislas
68  results:
Search for persons X
?
1

Single‐agent gemcitabine in patients with advanced, pre‐tre..:

Watson, Sarah ; Verret, Benjamin ; Ropert, Stanislas...
Cancer Medicine.  12 (2022)  3 - p. 3160-3166 , 2022
Link: https://doi.org/10.1002/..
 
?
2

Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients ..:

Guisier, Florian ; Dubos-Arvis, Catherine ; Viñas, Florent...
Journal of Thoracic Oncology.  15 (2020)  4 - p. 628-636 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Switch from abiraterone plus prednisone to abiraterone plus..:

Fenioux, Charlotte ; Louvet, Christophe ; Charton, Emilie...
BJU International.  123 (2018)  2 - p. 300-306 , 2018
Link: https://doi.org/10.1111/..
 
?
4

Colchicine is an active treatment for everolimus-induced or..:

Ropert, Stanislas ; Coriat, Romain ; Verret, Benjamin...
European Journal of Cancer.  87 (2017)  - p. 209-211 , 2017
Link: https://doi.org/10.1016/..
 
?
5

Everolimus induced mood changes in breast cancer patients: ..:

Mir, Olivier ; Salvador, Alexandre ; Dauchy, Sarah...
Investigational New Drugs.  36 (2017)  3 - p. 503-508 , 2017
Link: https://doi.org/10.1007/..
 
?
6

Pharmacokinetics and safety of DTS-108, a human oligopeptid..:

Coriat, Romain ; Faivre, Sandrine ; Mir, Olivier...
International Journal of Nanomedicine.  11 (2016)  - p. 6207-6216 , 2016
Link: https://doi.org/10.2147/..
 
?
7

Inaugural bone metastases in non-small cell lung cancer: a ..:

Deberne, Mélanie ; Ropert, Stanislas ; Billemont, Bertrand...
BMC Cancer.  14 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
8

Sarcopenia Predicts Early Dose-Limiting Toxicities and Phar..:

Mir, Olivier ; Coriat, Romain ; Blanchet, Benoit...
PLoS ONE.  7 (2012)  5 - p. e37563 , 2012
Link: https://doi.org/10.1371/..
 
?
9

Variability of Sorafenib Toxicity and Exposure over Time: A..:

Boudou-Rouquette, Pascaline ; Ropert, Stanislas ; Mir, Olivier...
The Oncologist.  17 (2012)  9 - p. 1204-1212 , 2012
Link: https://doi.org/10.1634/..
 
?
10

Interaction between serotonin reuptake inhibitors, 5-HT3 an..:

Mir, Olivier ; Durand, Jean-Philippe ; Boudou-Rouquette, Pascaline...
Supportive Care in Cancer.  20 (2012)  9 - p. 2235-2239 , 2012
Link: https://doi.org/10.1007/..
 
?
11

Gemcitabine and oxaliplatin as second-line treatment in pat..:

Mir, Olivier ; Coriat, Romain ; Boudou-Rouquette, Pascaline...
Medical Oncology.  29 (2012)  4 - p. 2793-2799 , 2012
Link: https://doi.org/10.1007/..
 
?
12

Pemetrexed, oxaliplatin and bevacizumab as first-line treat..:

Mir, Olivier ; Boudou-Rouquette, Pascaline ; Giroux, Julie...
Lung Cancer.  77 (2012)  1 - p. 104-109 , 2012
Link: https://doi.org/10.1016/..
 
?
13

Sorafenib exposure decreases over time in patients with hep..:

Arrondeau, Jennifer ; Mir, Olivier ; Boudou-Rouquette, Pascaline...
Investigational New Drugs.  30 (2011)  5 - p. 2046-2049 , 2011
Link: https://doi.org/10.1007/..
 
?
14

A simple HPLC-UV method for the simultaneous quantification..:

Faivre, Lionel ; Gomo, Charline ; Mir, Olivier...
Journal of Chromatography B.  879 (2011)  23 - p. 2345-2350 , 2011
Link: https://doi.org/10.1016/..
 
?
15

Reversible Decrease of Portal Venous Flow in Cirrhotic Pati..:

Coriat, Romain ; Gouya, Hervé ; Mir, Olivier...
PLoS ONE.  6 (2011)  2 - p. e16978 , 2011
Link: https://doi.org/10.1371/..
 
1-15